Impact of Cannabis Use, Substance Use Disorders, and Psychiatric Diagnoses on COVID-19 Outcomes
BS Divya Ramakrishnan, MS Soundari Sureshanand, MS Brian Pittman, MBBS Rajiv Radhakrishnan
The Journal of Clinical Psychiatry, doi:10.4088/jcp.21m14332
Early Career Psychiatrists CME Background Articles are selected for credit designation based on an assessment of the educational needs of CME participants, with the purpose of providing readers with a curriculum of CME articles on a variety of topics throughout each volume. Activities are planned using a process that links identified needs with desired results. To obtain credit, read the article, correctly answer the questions in the Posttest, and complete the Evaluation.
CME Objective After studying this article, you should be able to: • Understand which SUDs and other psychiatric patient subgroups may be more susceptible to severe COVID-19 infections and outcomes and better direct needed medical attention to these patients.
Accreditation Statement The CME Institute of Physicians Postgraduate Press, Inc., is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
Credit Designation The CME Institute of Physicians Postgraduate Press, Inc., designates this journal-based CME activity for a maximum of 1 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Note: The American Nurses Credentialing Center (ANCC) and the American Academy of Physician Assistants (AAPA) accept certificates of participation for educational activities certified for AMA PRA Category 1 Credit™ from organizations accredited by the ACCME.
For reprints or permissions, contact permissions@psychiatrist.com. ♦ © 2022 Copyright Physicians Postgraduate Press, Inc. It is illegal to post this copyrighted PDF on any website.
Posttest To obtain credit, go to CMEInstitute.com to take this Posttest and complete the Evaluation.
References
Allen, Shahawy, Rogers, Association of substance use disorders and drug overdose with adverse COVID-19 outcomes in New York City: January-October 2020, J Public Health (Oxf)
Baillargeon, Polychronopoulou, Kuo, The impact of substance use disorder on COVID-19 outcomes, Psychiatr Serv
Egede, Dawson, Walker, Relationship between mental health diagnoses and COVID-19 test positivity, hospitalization, and mortality in Southeast Wisconsin, Psychol Med,
doi:10.1017/S0033291721002312Fond, Nemani, Etchecopar-Etchart, Association between mental health disorders and mortality among patients with COVID-19 in 7 countries: a systematic review and metaanalysis, JAMA Psychiatry,
doi:10.1001/jamapsychiatry.2021.2274Fond, Pauly, Leone, Disparities in intensive care unit admission and mortality among patients with schizophrenia and COVID-19: a national cohort study, Schizophr Bull
Jeon, Kwon, Park, Association of mental disorders with SARS-CoV-2 infection and severe health outcomes: nationwide cohort study, Br J Psychiatry,
doi:10.1192/bjp.2020.251Lee, Yang, Moon, Association between mental illness and COVID-19 susceptibility and clinical outcomes in South Korea: a nationwide cohort study, Lancet Psychiatry,
doi:10.1016/S2215-0366(20)30421-1Li, Li, Fortunati, Association of a prior psychiatric diagnosis with mortality among hospitalized patients with coronavirus disease 2019 (COVID-19) infection, JAMA Netw Open,
doi:10.1001/jamanetworkopen.2020.23282Schimmel, Manini, Opioid use disorder and COVID-19: biological plausibility for worsened outcomes, Subst Use Misuse
Vai, Mazza, Colli, Mental disorders and risk of COVID-19-related mortality, hospitalisation, and intensive care unit admission: a systematic review and metaanalysis, Lancet Psychiatry,
doi:10.1016/S2215-0366(21)00232-7Wang, Kaelber, Xu, COVID-19 risk and outcomes in patients with substance use disorders: analyses from electronic health records in the United States, Mol Psychiatry
Wang, Xu, Volkow, Increased risk of COVID-19 infection and mortality in people with mental disorders: analysis from electronic health records in the United States, World Psychiatry
DOI record:
{
"DOI": "10.4088/jcp.21m14332",
"ISSN": [
"1555-2101"
],
"URL": "http://dx.doi.org/10.4088/JCP.21m14332",
"author": [
{
"affiliation": [],
"family": "Ramakrishnan",
"given": "Divya",
"sequence": "first"
},
{
"affiliation": [],
"family": "Sureshanand",
"given": "Soundari",
"sequence": "additional"
},
{
"affiliation": [],
"family": "Pittman",
"given": "Brian",
"sequence": "additional"
},
{
"affiliation": [],
"family": "Radhakrishnan",
"given": "Rajiv",
"sequence": "additional"
}
],
"container-title": "The Journal of Clinical Psychiatry",
"container-title-short": "J. Clin. Psychiatry",
"content-domain": {
"crossmark-restriction": false,
"domain": []
},
"created": {
"date-parts": [
[
2022,
8,
29
]
],
"date-time": "2022-08-29T13:02:55Z",
"timestamp": 1661778175000
},
"deposited": {
"date-parts": [
[
2022,
8,
29
]
],
"date-time": "2022-08-29T13:02:55Z",
"timestamp": 1661778175000
},
"indexed": {
"date-parts": [
[
2022,
8,
29
]
],
"date-time": "2022-08-29T13:41:42Z",
"timestamp": 1661780502465
},
"is-referenced-by-count": 0,
"issue": "5",
"issued": {
"date-parts": [
[
2022,
8,
29
]
]
},
"journal-issue": {
"issue": "5",
"published-online": {
"date-parts": [
[
2022,
8,
29
]
]
}
},
"member": "2558",
"original-title": [],
"prefix": "10.4088",
"published": {
"date-parts": [
[
2022,
8,
29
]
]
},
"published-online": {
"date-parts": [
[
2022,
8,
29
]
]
},
"publisher": "Physicians Postgraduate Press, Inc",
"reference-count": 0,
"references-count": 0,
"relation": {},
"resource": {
"primary": {
"URL": "https://www.psychiatrist.com/jcp/covid-19/impact-of-sud-on-covid-19-outcomes/"
}
},
"score": 1,
"short-title": [],
"source": "Crossref",
"subject": [
"Psychiatry and Mental health"
],
"subtitle": [
"A Retrospective Cohort Study"
],
"title": "Impact of Cannabis Use, Substance Use Disorders, and Psychiatric Diagnoses on COVID-19 Outcomes",
"type": "journal-article",
"volume": "83"
}
